I’ve been involved in the research chemical scene for a long time now and over time I’ve ingested many, many substances to extrapolate their effects. This is all research to find out the Buy Research Chemicals between different compounds. Basically what compounds hit which receptors and what happens next. On my own journey I’ve been as far as you can go in terms of “highness”!
However the research chemical scene today is dwindling. It’s still producing many novel compounds to bypass laws but only in the most popular areas, which appear to be the empathogens, stimulants and cannabinoids. We now have 5-EAPB, a-PVP, MPA and various cannabinoids which appear to pop up faster than you may even fully understand the last. My favourites in the cannabinoids have to be the cannabinoid re-uptake inhibitors such as LY-2183240. These compounds don’t actually agonise your cannabinoid receptors as Cannabis along with other cannabinoids do nonetheless they improve your own endogenous cannabinoids, so essentially you’re getting high off your very own juices! When they are along with agonists for example THC or other synthetic cannabinoids, they increase the high to this type of extent that a gram of weed could endure a week with say 20mg from the CRI’s! Seeing that is innovation.
I’m not here to speak to you about Dibutylone though. What exactly is really on my agenda is the absence of innovation inside the psychedelic realm. PIHKAL and TIHKAL have offered us countless compounds that could be made yet only the standard are marketed. Now for me this is a problem. I love novel psychedelics. In reality I could possibly name a few that we composed here and from now on (i.e. 2C-MAL, 4-Bromo-Mescaline, 4-PropO-PiPT etc.).
The fact of the matter is the fact no-the first is producing novel psychedelics anymore. We have seen several during the last year or two which were great including 3C-E and bk-2C-B but aside from those (rather meagre) psychedelics, we have seen no big bangs, which happens to be what I love. The compounds which can be a huge hit are: 5-TOET, ALEPH & ALEPH-2, 2C-EF, 2C-TFM, CPM, 2C-T-21, DMMDA, psi-DOx (these have lowered duration for those who aren’t fans of long psychedelics), MEM, MMDA-2, MMDA-3a (and it’s methyl analogue), MMDA itself (capable of producing ‘brain movies’) and a whole host of other analogues as an example 2C-C-FLY.
We have to give praise to some which can be producing such compounds though as DON, DOET, LSZ, AL-LAD and 2C-B-FLY have made it on the scene recently.
However my main message within this is that as darknets are expanding, the requirement for analogues and research chemicals has grown to be redundant. People would rather get yourself a gram of MDMA than the usual gram of bk-ebdp. They’d rather acquire some 2C-B than some 2C-T-16 or 2C-YN. The research chemical scene was previously thriving and everybody desired to make their 87dexlpky around the world. Just have a look at how well MXE did, and this is simply not even near to what is. With some imagination and drive, much better compounds could be created. They also have to be distributed with the retail end since there are many wholesalers who do produce fantastic products but customers are so dead set of what they are fully aware and wish there is absolutely no room for expansion.
Once we will be to evolve chemically we need to commence to abandon the essential drugs we understand and love. It’s a risky venture, obviously, but people who use drugs embark on risky behaviour at all times, why not expand those boundaries to let in a few of the fantastic compounds which are out there waiting being synthesized? This is certainly evolution at it’s simplest definition along with the introduction of Black Marketplaces it appears to be our company is at a lull, our company is not striving towards the future but perhaps, someday, we’ll wake up and realise that this compounds many have neglected are those that they want by far the most.